Background illustration for clinical trials search

Paid Clinical Trials Kansas

Discover 815 paid clinical trials in Kansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy

for
Arrhythmias, Cardiac, Atrial Fibrillation
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT04473807

Recruiting

Study of ATX-01 in Participants With DM1

for
Myotonic Dystrophy 1
Location: Chicoutimi, Richmond VA, Gainesville FL, Iowa City IA,
Sponsor: ARTHEx Biotech S.L.

Sex: All

Age: 18 - 64

Code: NCT06300307

Phase 1, Phase 2, Recruiting

Trial-Ready Cohort-Down Syndrome (TRC-DS)

for
Down Syndrome, Alzheimer Disease, Dementia
Location: Boston MA, Staten Island NY, Pittsburgh PA,
Sponsor: University of Southern California

Sex: All

Age: 25 - 55

Code: NCT04165109

Recruiting

Opioid-Free Pain Treatment in Trauma Patients

for
Femoral Neck Fractures, Intertrochanteric Fractures,
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT06078371

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: Boston MA, Philadelphia PA, Fairfax VA, Detroit MI,
Sponsor: Frontier Medicines Corporation

Sex: All

Age: 18+

Code: NCT06244771

Phase 1, Phase 2, Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for
Idiopathic Pulmonary Fibrosis
Location: Farmington CT, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals

Sex: All

Age: 40+

Code: NCT05571059

Phase 2, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: St. John's, Moncton, Boston MA, Bristol CT, Hamden CT,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase 3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Study of APVO436 in Patients With AML or MDS

for
AML, MDS
Location: Miami FL, Gainesville FL, Greenville SC, Columbus OH,
Sponsor: Aptevo Research and Development LLC

Sex: All

Age: 18+

Code: NCT03647800

Phase 1, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Burlington MA, Norfolk MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Sydney, Boston MA, Providence RI, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for
Carcinoma, Non-Small Cell Lung,
Location: Boston MA, Newton MA, Shirley NY, Riverhead NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04389632

Phase 1, Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for
Adult Acute Myeloid Leukemia
Location: Baltimore MD, Rochester NY, Tampa FL, Cleveland OH,
Sponsor: Priothera SAS

Sex: All

Age: 18 - 70+

Code: NCT05429632

Phase 3, Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Saint Johnsbury VT, Lebanon NH, New York NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05633615

Phase 2, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Lake Success NY,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase 3, Recruiting

Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib

for
Mutant IDH1 Inhibitor Olutasidenib
Location: Boston MA, Miami FL, Buffalo NY, Westwood KS,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06445959

Phase 1, Phase 2, Recruiting

Popular cities in Kansas

With a well-established healthcare network and renowned medical research institutions, Kansas has emerged as a significant hub for a wide range of clinical trials. Leading institutions such as The University of Kansas Medical Center, Wesley Medical Center, and Children's Mercy Kansas City are at the forefront of groundbreaking studies.

These centers are recognized for their contributions to innovative medical research, helping to advance treatments in fields such as oncology, cardiology, and pediatrics.

Why choose Kansas for clinical trials?

Kansas offers unique advantages for those participating in clinical trials. The state’s central location, combined with a mix of urban and rural populations, provides a diverse range of participants, making research findings more comprehensive and applicable to various communities. Kansas is also known for its collaborative research environment, where major institutions work closely with local healthcare providers to drive medical advancements.

By participating in a clinical trial in Kansas, volunteers contribute to critical research efforts while benefiting from a supportive, patient-focused clinical research system that emphasizes innovation and community engagement.

Common conditions studied in Kansas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Kansas